新型多团注对比剂注射方案用于胸腹CT血管成像的临床评估:动脉对比增强均匀性评价
研究纳入63例胸腹CTA患者,其中48例无主动脉夹层(组1)和15例主动脉夹层(组2)接受多团注方案(60 ml对比剂);组1中18例另接受单团注方案(94 ml)。多团注方案98%病例平均衰减>200 HU,沿扫描长度的衰减标准差更低(p=0.003),但单团注方案平均衰减更高(p=0.002);多团注方案在主动脉夹层中真/假腔充盈更均匀(p=0.012)。
要点
- 多团注方案(60 ml)在98%病例中维持平均衰减>200 HU。
- 多团注方案沿扫描长度衰减标准差更低(p=0.003),均匀性优于单团注。
- 单团注方案(94 ml)平均衰减更高(p=0.002)。
核心结论
- 多团注方案在胸腹CTA中临床可行,在有无主动脉夹层患者中均显示持续高动脉增强和优于单团注的对比均匀性。
研究设计与样本
- 单中心前瞻性可行性研究,共63例胸腹CTA患者,多团注方案使用60 ml对比剂;组1无主动脉夹层(n=48),组2主动脉夹层(n=15)。
- 组1中18例另行单团注方案(94 ml对比剂)检查,用于两种方案比较;组2分别评估单团注和多团注方案下真腔与假腔的衰减差异。
- 组1采用手动ROI分析(10个节段)及半自动线性衰减剖面测量主动脉对比增强;比较采用Wilcoxon检验。
关键影像表现/征象
- 多团注方案98%病例平均衰减>200 HU。
- 多团注方案沿扫描长度的衰减标准差低于单团注方案(p=0.003)。
- 单团注方案平均衰减高于多团注方案(p=0.002)。
- 主动脉夹层患者中,多团注方案因增强平台延长使真腔和假腔显影更均匀(p=0.012)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
PURPOSE: To evaluate the in vivo feasibility of a multibolus contrast agent (CA) injection protocol with a reduced CA volume for thoraco-abdominal CT angiography (CTA) and to compare it to a single-bolus CA injection protocol.
METHOD: 63 patients who underwent CTA with the multibolus protocol (60 ml CA) were divided in two groups either without (group 1, n = 48) or with (group 2, n = 15) aortic dissection. The aortic contrast enhancement was measured in group 1 using manual ROI analysis (10 segments), as well as semi-automated linear attenuation profiles. A subgroup (n = 18) of group 1, who also underwent imaging with the single-bolus protocol (94 ml CA), was used to compare both protocols. In group 2, differences in attenuation of the true and the false lumen for both the single- and the multibolus protocol were assessed with ROI attenuation measurements in both lumina. Comparisons were made using Wilcoxon test.
RESULTS: Average attenuation was above 200 HU for 98 % of cases using the multibolus protocol. There was superior contrast homogeneity for the multibolus protocol with a lower standard deviation of attenuation values along the length of the scan (p = 0.003), while average attenuation was higher for the single-bolus protocol (p = 0.002). Prolonged enhancement plateau lead to a more uniform opacification of the true and the false lumen in patients with aortic dissection using the multibolus protocol (p = 0.012).
CONCLUSIONS: The multibolus protocol in thoraco-abdominal CTA is feasible in patients. It shows consistently high arterial enhancement with superior contrast homogeneity compared to a single-bolus protocol in patients with and without aortic dissection.
引用
- Obmann MM, Gehweiler J, Schindera ST, et al. Clinical evaluation of a novel multibolus contrast agent injection protocol for thoraco-abdominal CT angiography: Assessment of homogeneity of arterial contrast enhancement. Eur J Radiol. 2020. PMID: 32244065. doi:10.1016/j.ejrad.2020.108957
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。